Does Dr. MICHAEL BARRETT have financial conflicts of interest?

Dr. MICHAEL BARRETT (MD) has received a total of $128 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $128 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MICHAEL BARRETT?

According to CMS Open Payments data, Dr. MICHAEL BARRETT received funding from LA JOLLA PHARMACEUTICAL COMPANY ($94), MEDTRONIC ($21), and ASTRAZENECA PHARMACEUTICALS ($14).

Does Dr. MICHAEL BARRETT receive research grants or speaking fees?

Dr. MICHAEL BARRETT has received $128 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MICHAEL BARRETT

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: FISHERSVILLE, VA 22939

NPI Number: 1437122603

LIFETIME INDUSTRY VALUE

$128

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BARRETT is a verified Internal Medicine practitioner based in FISHERSVILLE, VA.

Between 2021 and 2024, Dr. BARRETT had an overall industry promotional and research financial footprint of $128 as recorded in the federal CMS Open Payments database.

$128 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BARRETT's primary funding source is LA JOLLA PHARMACEUTICAL COMPANY, which accounts for $94 (representing 73.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

LA JOLLA PHARMACEUTICAL COMPANY

Rank 1

$94

73.1%

MEDTRONIC

Rank 2

$21

16.1%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$14

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.